Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Chirag, Bavishi"'
Autor:
Chirag Bavishi
Publikováno v:
US Cardiology Review, Vol 17, Iss , Pp - (2023)
Transcatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF. In this concise review article, the Food and Drug Administrati
Externí odkaz:
https://doaj.org/article/b806a320d61a489998b57bbc21bc9613
Autor:
Kelsey Anderson, Chirag Bavishi, Dhaval Kolte, Reginald Gohh, James A Arrighi, Philip Stockwell, J Dawn Abbott
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260718 (2021)
Cardiovascular risk stratification is often performed in patients considered for renal transplantation. In a single center, we sought to examine the association between abnormal stress testing with imaging and post-renal transplant major adverse card
Externí odkaz:
https://doaj.org/article/d75ecd6fd9e34a21ae0d6f47f59ac643
Autor:
Kalyan R. Chitturi, Shubham Kanake, Thai Nguyen, Brian Loc, Kristina Baden, Chirag Bavishi, Arun Kumar, Zhenguo Liu, Albert Chan, Poorna R. Karuparthi, Taishi Hirai
Publikováno v:
Cardiovascular Revascularization Medicine. 43:115-119
How to implement robotic-assisted PCI safely and when to escalate to more complex cases has not been previously described. We sought to evaluate clinical outcomes in patients undergoing robotic-assisted PCI in the first year of a newly established ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d290e9e625c1944888146d133d31dd2d
https://doi.org/10.1016/j.carrev.2022.05.022
https://doi.org/10.1016/j.carrev.2022.05.022
Autor:
Franz H. Messerli, Chirag Bavishi, Jana Brguljan, Michel Burnier, Stephan Dobner, Fernando Elijovich, Keith C. Ferdinand, Sverre Kjeldsen, Cheryl L. Laffer, C. Venkata S Ram, Emrush Rexhaj, Luis M. Ruilope, Evgeniya V. Shalaeva, George C.M. Siontis, Jan A. Staessen, Stephen C. Textor, Wanpen Vongpatanasin, Liffert Vogt, Massimo Volpe, Jiguang Wang, Bryan Williams
Publikováno v:
Journal of hypertension, 40(10), 1859-1875. Lippincott Williams and Wilkins
Even though it has been more than a decade since renal denervation (RDN) was first used to treat hypertension and an intense effort on researching this therapy has been made, it is still not clear how RDN fits into the antihypertensive arsenal. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1434e37793188b73b718de83994e0e82
https://doi.org/10.1097/hjh.0000000000003171
https://doi.org/10.1097/hjh.0000000000003171
Autor:
Michael U, Williams, William R, Lang, Tyler, Wark, Gerry, Ovide, Rei, Mitsuyama, Vishnu, Kadiyala, Sokunvichet, Long, Robert E, Heinl, Mustapha Ousman, Kah, Esseim, Sharma, Omar N, Hyder, Chirag, Bavishi, Kevin F, Kennedy, Herbert, Aronow, J Dawn, Abbott
Publikováno v:
Cardiovascular Revascularization Medicine. 42:154-158
Ticagrelor or prasugrel are recommended to reduce ischemic events in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). However, in clinical practice, patients are often switched from a potent P2Y12 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430bec3d4f2807e1910a7335757c0a20
https://doi.org/10.1016/j.carrev.2022.01.029
https://doi.org/10.1016/j.carrev.2022.01.029
Autor:
Chirag Bavishi
Publikováno v:
Annals of internal medicine.
Cholesterol Treatment Trialists' Collaboration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a651aacf0b221a953771dc0070c4413
https://pubmed.ncbi.nlm.nih.gov/36592471
https://pubmed.ncbi.nlm.nih.gov/36592471
Autor:
Chirag Bavishi
Publikováno v:
Annals of internal medicine. 175(12)
Mullens W, Dauw J, Martens P, et al.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba89ce146b6e0b57333d0505e579e0e
https://pubmed.ncbi.nlm.nih.gov/36469916
https://pubmed.ncbi.nlm.nih.gov/36469916
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES.
The American Heart Association/American College of Cardiology guidelines on dual antiplatelet therapy (DAPT) recommend at least 12 months of a P2Y12 inhibitor and low dose aspirin in patients with an acute coronary syndrome (ACS) treated with a stent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9a8aad0dff936ecba30c8feda16f78
https://pubmed.ncbi.nlm.nih.gov/36326115
https://pubmed.ncbi.nlm.nih.gov/36326115
Autor:
J. Dawn Abbott, Chirag Bavishi
Publikováno v:
Interventional Cardiology Clinics. 10:307-316
Intravenous anticoagulation is standard of care in the treatment of ST-elevation myocardial infarction. Primary percutaneous coronary intervention is the most common reperfusion strategy. Four anticoagulant options are available: unfractionated hepar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570bb09cc5d1ebbe7c11a6774dd60b2b
https://doi.org/10.1016/j.iccl.2021.03.003
https://doi.org/10.1016/j.iccl.2021.03.003
Publikováno v:
Hypertension
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are equally guideline-recommended first-line treatments for hypertension yet few head-to-head studies exist. We compared the real-world effectiveness and safety o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77dabb8f0078b21fde04ae4560269060
https://doi.org/10.1161/circulationaha.121.057835
https://doi.org/10.1161/circulationaha.121.057835